血液型の市場規模、シェア、動向分析レポート：製品・サービス別、検査タイプ別、手法別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

血液型市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の血液型市場規模は2030年までに38億3,000万米ドルに達すると予測され、2024年から2030年までのCAGRは10.3%で成長すると予測されています。

この成長は、交通事故や緊急事態によって必要とされる輸血件数の増加とともに、法医学や出生前検査における血液型の利用が増加していることが背景にあります。

血液型は、O、A、B、AB群を識別し、ドナーとレシピエント間の適合性を確保し、Rh因子を決定する重要なプロセスです。これは、発見されないと命にかかわる新生児の溶血性疾患（HDN）を予防するための出生前検査において特に重要です。市場の成長は、輸血を必要とする交通事故や緊急事態の増加、献血件数の増加にも支えられています。

CDCによると、交通事故により年間約135万人の命が奪われており、安全な輸血を確保する上で血液型の重要な役割が浮き彫りになっています。病院における保管能力の向上など、多くの国々における高度な医療インフラは、タイピングとクロスマッチングのための血液サンプルの保管と入手を容易にすることで、市場の成長をさらに後押ししています。輸血を必要とする事故や外傷の増加も市場成長の主要因です。外科的介入を必要とする患者における輸血の緊急な必要性も、主要な促進要因として作用します。

さらに、潜在的な合併症を管理するために血液型を必要とする出生前検査も重要な促進要因です。HDNを予防するために妊婦に正確な血液型を行う必要性は、市場の成長をさらに促進すると予想されます。さらに、法医学における血液型の需要の高まりも市場の拡大に寄与しています。

さらに、市場参入企業は、診断技術の進歩に貢献する新たなイニシアチブの革新と導入に努めています。これらのイニシアチブは、市場のダイナミクスを形成し、患者ケアの改善を促進し、ヘルスケアプロバイダーの進化するニーズに対応する上で極めて重要な役割を果たしています。市場のプレーヤーは、専門知識とリソースを活用することで、ヘルスケアのエコシステムにおける効率性、正確性、アクセシビリティを高める革新的なソリューションを導入しています。例えば、Quotient Limitedは2022年3月にMosaiQ Extended Immunohematology MicroarrayのCEマークを取得し、単一プラットフォーム上での抗体スクリーニング、抗原タイピング、ABOグループ分けによる血液型判定機能を強化し、ワークフローの改善と臨床的価値の向上を約束しました。このようなイニシアチブの市場プレーヤーは、診断技術の進歩に重点を置き、より広範なヘルスケア市場に貢献しています。

血液型市場のレポートハイライト

• 試薬・消耗品セグメントは、2023年に71.7%の最大収益シェアで市場をリードし、予測期間中に有利なCAGRで成長すると予測されます。
• 検査タイプ別では、抗体スクリーニング分野が2023年に38.6%の最大収益シェアで市場をリードし、HLAタイピング分野は市場において先進的かつ革新的な診断法の開発により、予測期間中最も速いCAGRで成長すると推計されます。
• 技術別では、PCRベースおよびマイクロアレイベースのセグメントが2023年に52.1%の最大収益シェアで市場をリードし、予測期間中に最も速いCAGRで成長すると予測されています。
• 用途別では、診断検査分野が2023年に54.1%の最大収益シェアで市場をリードしました。臓器移植セグメントは予測期間中最も速いCAGRで成長すると予測されています。
• 最終用途別では、診断検査部門が2023年に43.4%の最大収益シェアで市場をリードしました。
• 北米は2023年に44.6％の収益シェアで市場を独占したが、これは高度なヘルスケアインフラ、慢性疾患の有病率の上昇、良好な規制環境などの要因によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 血液型市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 血液型市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
• 価格分析

第4章 血液型市場：製品とサービスの推定・動向分析

• 血液型市場：製品とサービスのダッシュボード
• 世界の血液型市場変動分析
• 製品とサービス別の世界の血液型市場の見通し
• 機器
• 試薬・消耗品
• サービス

第5章 血液型市場： 検査タイプの推定・動向分析

• 血液型市場：検査タイプダッシュボード
• 世界の血液型市場変動分析
• 検査タイプ別：世界の血液型市場の見通し
• 抗体スクリーニング
• HLA型
• クロスマッチング検査
• ABO血液検査
• その他

第6章 血液型市場：技術の推定・動向分析

• 血液型判定市場：技術ダッシュボード
• 世界の血液型市場変動分析
• 技術別：世界の血液型市場の展望
• PCRベースとマイクロアレイベース
• アッセイベースの技術
• 超並列シーケンシング
• その他

第7章 血液型市場：用途の推定・動向分析

• 血液型判定市場：用途ダッシュボード
• 世界の血液型市場変動分析
• 用途別：世界の血液型市場の展望
• 輸血
• 臓器移植
• 診断検査

第8章 血液型市場：最終用途の推定・動向分析

• 血液型市場：最終用途ダッシュボード
• 世界の血液型市場変動分析
• 最終用途別：世界の血液型市場の展望
• 病院・診療所
• 診断検査室
• 血液銀行
• その他

第9章 血液型市場：製品・サービス、検査タイプ、技術、用途、最終用途別の地域推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018年から2030年
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要ディストリビューターおよびチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2023年
  • Mesa Laboratories, Inc.（Agena Bioscience, Inc.）
  • Danaher Corporation（Beckman Coulter）
  • Bio-Rad Laboratories, Inc
  • DIAGAST
  • Grifols, SA
  • AXO Science
  • Merck KGaA
  • Thermo Fisher Scientific
  • Immucor, Inc.
  • BAG Diagnostics GmbH
  • Seegene Inc.

List of Tables

• Table 1. List of abbreviation
• Table 2. North America blood typing market, by region, 2018 - 2030 (USD Million)
• Table 3. North America blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 4. North America blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 5. North America blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 6. North America blood typing market, by application, 2018 - 2030 (USD Million)
• Table 7. North America blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 8. U.S. blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 9. U.S. blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 10. U.S. blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 11. U.S. blood typing market, by application, 2018 - 2030 (USD Million)
• Table 12. U.S. blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 13. Canada blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 14. Canada blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 15. Canada blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 16. Canada blood typing market, by application, 2018 - 2030 (USD Million)
• Table 17. Canada blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 18. Europe blood typing market, by region, 2018 - 2030 (USD Million)
• Table 19. Europe blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 20. Europe blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 21. Europe blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 22. Europe blood typing market, by application, 2018 - 2030 (USD Million)
• Table 23. Europe blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 24. Germany blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 25. Germany blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 26. Germany blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 27. Germany blood typing market, by application, 2018 - 2030 (USD Million)
• Table 28. Germany blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 29. UK blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 30. UK blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 31. UK blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 32. UK blood typing market, by application, 2018 - 2030 (USD Million)
• Table 33. UK blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 34. France blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 35. France blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 36. France blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 37. France blood typing market, by application, 2018 - 2030 (USD Million)
• Table 38. France blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 39. Italy blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 40. Italy blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 41. Italy blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 42. Italy blood typing market, by application, 2018 - 2030 (USD Million)
• Table 43. Italy blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 44. Spain blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 45. Spain blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 46. Spain blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 47. Spain blood typing market, by application, 2018 - 2030 (USD Million)
• Table 48. Spain blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 49. Denmark blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 50. Denmark blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 51. Denmark blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 52. Denmark blood typing market, by application, 2018 - 2030 (USD Million)
• Table 53. Denmark blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 54. Sweden blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 55. Sweden blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 56. Sweden blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 57. Sweden blood typing market, by application, 2018 - 2030 (USD Million)
• Table 58. Sweden blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 59. Norway blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 60. Norway blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 61. Norway blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 62. Norway blood typing market, by application, 2018 - 2030 (USD Million)
• Table 63. Norway blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 64. Asia Pacific blood typing market, by region, 2018 - 2030 (USD Million)
• Table 65. Asia Pacific blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 66. Asia Pacific blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 67. Asia Pacific blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 68. Asia Pacific blood typing market, by application, 2018 - 2030 (USD Million)
• Table 69. Asia Pacific blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 70. China blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 71. China blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 72. China blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 73. China blood typing market, by application, 2018 - 2030 (USD Million)
• Table 74. China blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 75. Japan blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 76. Japan blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 77. Japan blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 78. Japan blood typing market, by application, 2018 - 2030 (USD Million)
• Table 79. Japan blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 80. India blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 81. India blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 82. India blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 83. India blood typing market, by application, 2018 - 2030 (USD Million)
• Table 84. India blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 85. South Korea blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 86. South Korea blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 87. South Korea blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 88. South Korea blood typing market, by application, 2018 - 2030 (USD Million)
• Table 89. South Korea blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 90. Australia blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 91. Australia blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 92. Australia blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 93. Australia blood typing market, by application, 2018 - 2030 (USD Million)
• Table 94. Australia blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 95. Thailand blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 96. Thailand blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 97. Thailand blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 98. Thailand blood typing market, by application, 2018 - 2030 (USD Million)
• Table 99. Thailand blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 100. Latin America blood typing market, by region, 2018 - 2030 (USD Million)
• Table 101. Latin America blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 102. Latin America blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 103. Latin America blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 104. Latin America blood typing market, by application, 2018 - 2030 (USD Million)
• Table 105. Latin America blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 106. Brazil blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 107. Brazil blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 108. Brazil blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 109. Brazil blood typing market, by application, 2018 - 2030 (USD Million)
• Table 110. Brazil blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 111. Mexico blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 112. Mexico blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 113. Mexico blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 114. Mexico blood typing market, by application, 2018 - 2030 (USD Million)
• Table 115. Mexico blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 116. Argentina blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 117. Argentina blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 118. Argentina blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 119. Argentina blood typing market, by application, 2018 - 2030 (USD Million)
• Table 120. Argentina blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 121. MEA blood typing market, by region, 2018 - 2030 (USD Million)
• Table 122. MEA blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 123. MEA blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 124. MEA blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 125. MEA blood typing market, by application, 2018 - 2030 (USD Million)
• Table 126. MEA blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 127. South Africa blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 128. South Africa blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 129. South Africa blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 130. South Africa blood typing market, by application, 2018 - 2030 (USD Million)
• Table 131. South Africa blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 132. Saudi Arabia blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 133. Saudi Arabia blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 134. Saudi Arabia blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 135. Saudi Arabia blood typing market, by application, 2018 - 2030 (USD Million)
• Table 136. Saudi Arabia blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 137. UAE blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 138. UAE blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 139. UAE blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 140. UAE blood typing market, by application, 2018 - 2030 (USD Million)
• Table 141. UAE blood typing market, by end-use, 2018 - 2030 (USD Million)
• Table 142. Kuwait blood typing market, by product & services, 2018 - 2030 (USD Million)
• Table 143. Kuwait blood typing market, by test type, 2018 - 2030 (USD Million)
• Table 144. Kuwait blood typing market, by technique, 2018 - 2030 (USD Million)
• Table 145. Kuwait blood typing market, by application, 2018 - 2030 (USD Million)
• Table 146. Kuwait blood typing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Blood typing market: market outlook
• Fig. 14 Blood typing competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Blood typing market driver impact
• Fig. 18 Blood typing market restraint impact
• Fig. 19 Blood typing market: Product & services movement analysis
• Fig. 20 Blood typing market: Product & services outlook and key takeaways
• Fig. 21 Instruments market estimates and forecast, 2018 - 2030
• Fig. 22 Reagents & consumables estimates and forecast, 2018 - 2030
• Fig. 23 RBC reagents estimates and forecast, 2018 - 2030
• Fig. 24 Antisera reagents estimates and forecast, 2018 - 2030
• Fig. 25 Anti Human Globulin Reagents estimates and forecast, 2018 - 2030
• Fig. 26 Blood Saline Reagents estimates and forecast, 2018 - 2030
• Fig. 27 Services market estimates and forecast, 2018 - 2030
• Fig. 28 Blood typing market: Test type movement analysis
• Fig. 29 Blood typing market: Test type outlook and key takeaways
• Fig. 30 Antibody screening market estimates and forecast, 2018 - 2030
• Fig. 31 HLA Typing estimates and forecast, 2018 - 2030
• Fig. 32 Cross-matching tests market estimates and forecast, 2018 - 2030
• Fig. 33 ABO blood tests market estimates and forecast, 2018 - 2030
• Fig. 34 Others estimates and forecast, 2018 - 2030
• Fig. 35 Blood typing market: Technique movement analysis
• Fig. 36 Blood typing market: Technique outlook and key takeaways
• Fig. 37 PCR based and Microarray based market estimates and forecast, 2018 - 2030
• Fig. 38 Assay based techniques market estimates and forecast, 2018 - 2030
• Fig. 39 Massively parallel sequencing market estimates and forecast, 2018 - 2030
• Fig. 40 Others estimates and forecast, 2018 - 2030
• Fig. 41 Blood typing market: Application movement analysis
• Fig. 42 Blood typing market: Application outlook and key takeaways
• Fig. 43 Blood transfusions market estimates and forecast, 2018 - 2030
• Fig. 44 Organ transplants estimates and forecast, 2018 - 2030
• Fig. 45 Diagnostic testing market estimates and forecast, 2018 - 2030
• Fig. 46 Blood typing market: End-use movement analysis
• Fig. 47 Blood typing market: End-use outlook and key takeaways
• Fig. 48 Hospitals & clinics market estimates and forecast, 2018 - 2030
• Fig. 49 Diagnostic laboratories estimates and forecast, 2018 - 2030
• Fig. 50 Blood banks estimates and forecast, 2018 - 2030
• Fig. 51 Others market estimates and forecast, 2018 - 2030
• Fig. 52 Global blood typing market: Regional movement analysis
• Fig. 53 Global blood typing market: Regional outlook and key takeaways
• Fig. 54 Global blood typing market share and leading players
• Fig. 55 North America, by country
• Fig. 56 North America market estimates and forecasts, 2018 - 2030
• Fig. 57 U.S. key country dynamics
• Fig. 58 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 59 Canada key country dynamics
• Fig. 60 Canada market estimates and forecasts, 2018 - 2030
• Fig. 61 Europe market estimates and forecasts, 2018 - 2030
• Fig. 62 U.K. key country dynamics
• Fig. 63 U.K. market estimates and forecasts, 2018 - 2030
• Fig. 64 Germany key country dynamics
• Fig. 65 Germany market estimates and forecasts, 2018 - 2030
• Fig. 66 France key country dynamics
• Fig. 67 France market estimates and forecasts, 2018 - 2030
• Fig. 68 Italy key country dynamics
• Fig. 69 Italy market estimates and forecasts, 2018 - 2030
• Fig. 70 Spain key country dynamics
• Fig. 71 Spain market estimates and forecasts, 2018 - 2030
• Fig. 72 Denmark key country dynamics
• Fig. 73 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 74 Sweden key country dynamics
• Fig. 75 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 76 Norway key country dynamics
• Fig. 77 Norway market estimates and forecasts, 2018 - 2030
• Fig. 78 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 79 China key country dynamics
• Fig. 80 China market estimates and forecasts, 2018 - 2030
• Fig. 81 Japan key country dynamics
• Fig. 82 Japan market estimates and forecasts, 2018 - 2030
• Fig. 83 India key country dynamics
• Fig. 84 India market estimates and forecasts, 2018 - 2030
• Fig. 85 Thailand key country dynamics
• Fig. 86 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 87 South Korea key country dynamics
• Fig. 88 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 89 Australia key country dynamics
• Fig. 90 Australia market estimates and forecasts, 2018 - 2030
• Fig. 91 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 92 Brazil key country dynamics
• Fig. 93 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 94 Mexico key country dynamics
• Fig. 95 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 96 Argentina key country dynamics
• Fig. 97 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 98 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 99 South Africa key country dynamics
• Fig. 100 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 101 Saudi Arabia key country dynamics
• Fig. 102 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 103 UAE key country dynamics
• Fig. 104 UAE market estimates and forecasts, 2018 - 2030
• Fig. 105 Kuwait key country dynamics
• Fig. 106 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 107 Market share of key market players- Blood typing market

Blood Typing Market Growth & Trends:

The global blood typing market size is anticipated to reach USD 3.83 billion by 2030 and is projected to grow at a CAGR of 10.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. This growth is fueled by the increasing usage of blood group typing in forensic sciences and prenatal testing, alongside the rising number of blood transfusions necessitated by road accidents and emergencies.

Blood group typing is a critical process that identifies the O, A, B, and AB groups, ensuring compatibility between donors and recipients and determining the Rh factor. This is particularly crucial in prenatal testing to prevent Hemolytic Disease of the Newborn (HDN), a condition that can be fatal if not detected. The market's growth is also supported by the growing number of road accidents and emergencies, which necessitate transfusions, and the increasing number of donations.

According to CDC, road accidents claim approximately 1.35 million lives annually, highlighting the critical role of blood group typing in ensuring safe transfusions. The advanced medical infrastructure in many countries, including increased storage capacities in hospitals, further supports the market's growth by facilitating the storage and availability of blood samples for typing and cross-matching. The rise in accidents and trauma cases requiring blood transfusions is another key factor for the market growth. The urgent need for transfusion in patients requiring surgical intervention also acts as a key driving factor.

Furthermore, prenatal testing, which requires blood group typing to manage potential complications, is another significant driver. The need for accurate blood group typing in pregnant women to prevent HDN is anticipated to further drive the market's growth. In addition, the increasing demand for blood group typing in forensic sciences contributes to the market's expansion.

Moreover, market players are striving to innovate and introduce new initiatives that contribute to the advancement of diagnostic technologies. These initiatives play a pivotal role in shaping the dynamics of the market, driving improvements in patient care, and addressing the evolving needs of healthcare providers. By leveraging their expertise and resources, market players introduce innovative solutions that enhance efficiency, accuracy, and accessibility within the healthcare ecosystem. For instance, in March 2022, Quotient Limited obtains CE Mark for MosaiQ Extended Immunohematology Microarray, enhancing blood typing capabilities with Antibody Screening, Antigen Typing, and ABO grouping on a single platform, promising improved workflow and clinical value. Such initiatives market players contribute to the broader healthcare market, with a focus on advancements in diagnostic technologies.

Blood Typing Market Report Highlights:

• The reagents and consumables segment led the market with the largest revenue share of 71.7% in 2023 and is anticipated to grow at the lucrative CAGR over the forecast period, owing to extensive R&D initiatives being undertaken by major players for development of novel kits
• Based on test type, the antibody screening segment led the market with the largest revenue share of 38.6% in 2023, whereas HLA typing segment is estimated to grow at the fastest CAGR over the forecast period, owing to the development of advanced and innovative diagnostics in the market
• Based on technique, the PCR based and microarray based segment led the market with the largest revenue share of 52.1% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period
• Based on application, the diagnostic testing segment led the market with the largest revenue share of 54.1% in 2023. The organ transplants segment is estimated to grow at the fastest CAGR over the forecast period
• Based on end-use, the diagnostic laboratories segment led the market with the largest revenue share of 43.4% in 2023, owing to large number of tests being done at the facilities
• North America dominated the market with the revenue share of 44.6% in 2023, owing to factors such as advanced healthcare infrastructure, rising prevalence of chronic diseases, and favorable regulatory environment

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product & Services
  • 1.2.2. Test Type
  • 1.2.3. Technique
  • 1.2.4. Application
  • 1.2.5. End-use
  • 1.2.6. Regional scope
  • 1.2.7. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product & services outlook
  • 2.2.2. Test type outlook
  • 2.2.3. Technique outlook
  • 2.2.4. Application outlook
  • 2.2.5. End-use outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Blood Typing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for blood group typing in prenatal testing
    • 3.2.1.2. Growing number of road accidents, emergencies, and trauma cases necessitating transfusions
    • 3.2.1.3. Rising number of blood donations
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Poor blood service infrastructure
    • 3.2.2.2. Lack of awareness and skilled professionals
• 3.3. Blood Typing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
• 3.4. Pricing Analysis

Chapter 4. Blood Typing Market: Product & Services Estimates & Trend Analysis

• 4.1. Blood Typing Market: Product & Services Dashboard
• 4.2. Global Blood Typing Market Movement Analysis
• 4.3. Global Blood Typing Market by Product & Services Outlook
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Reagents & Consumables
  • 4.5.1. Reagents & consumables market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.1.1. RBC reagents
    • 4.5.1.1.1. RBC Reagents Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.1.2. Antisera reagents
    • 4.5.1.2.1. Antisera Reagents Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.1.3. Anti-Human Globulin Reagents
    • 4.5.1.3.1. Anti-Human Globulin Reagents Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.1.4. Blood Saline Reagents
    • 4.5.1.4.1. Blood Saline Reagents Market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Blood Typing Market: Test Type Estimates & Trend Analysis

• 5.1. Blood Typing Market: Test Type Dashboard
• 5.2. Global Blood Typing Market Movement Analysis
• 5.3. Global Blood Typing Market by Test Type Outlook
• 5.4. Antibody Screening
  • 5.4.1. Antibody screening market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. HLA Typing
  • 5.5.1. Molecular diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Cross-Matching Tests
  • 5.6.1. Cross-matching tests market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. ABO blood Tests
  • 5.7.1. ABO blood tests market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Blood Typing Market: Technique Estimates & Trend Analysis

• 6.1. Blood Typing Market: Technique Dashboard
• 6.2. Global Blood Typing Market Movement Analysis
• 6.3. Global Blood Typing Market by Technique Outlook
• 6.4. PCR based and Microarray based
  • 6.4.1. PCR based and Microarray based market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Assay based techniques
  • 6.5.1. Assay based techniques market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Massively Parallel Sequencing
  • 6.6.1. Massively Parallel Sequencing market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Blood Typing Market: Application Estimates & Trend Analysis

• 7.1. Blood Typing Market: Application Dashboard
• 7.2. Global Blood Typing Market Movement Analysis
• 7.3. Global Blood Typing Market by Application Outlook
• 7.4. Blood transfusions
  • 7.4.1. Blood transfusions market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Organ transplants
  • 7.5.1. Organ transplants market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Diagnostic testing
  • 7.6.1. Diagnostic testing market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Blood Typing Market: End-use Estimates & Trend Analysis

• 8.1. Blood Typing Market: End-use Dashboard
• 8.2. Global Blood Typing Market Movement Analysis
• 8.3. Global Blood Typing Market by End-use Outlook
• 8.4. Hospitals & clinics
  • 8.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Diagnostic laboratories
  • 8.5.1. Diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Blood banks
  • 8.6.1. Blood banks market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Others
  • 8.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Blood Typing Market: Regional Estimates & Trend Analysis by Product & Services, Test Type, Technique, Application and End-use

• 9.1. Regional Dashboard
• 9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.3. North America
  • 9.3.1. U.S.
    • 9.3.1.1. Key country dynamics
    • 9.3.1.2. Regulatory framework/ reimbursement structure
    • 9.3.1.3. Competitive scenario
    • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.2. Canada
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework/ reimbursement structure
    • 9.3.2.3. Competitive scenario
    • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Regulatory framework/ reimbursement structure
    • 9.4.1.3. Competitive scenario
    • 9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework/ reimbursement structure
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework/ reimbursement structure
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework/ reimbursement structure
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework/ reimbursement structure
    • 9.4.5.3. Competitive scenario
    • 9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.6. Norway
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework/ reimbursement structure
    • 9.4.6.3. Competitive scenario
    • 9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework/ reimbursement structure
    • 9.4.7.3. Competitive scenario
    • 9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Regulatory framework/ reimbursement structure
    • 9.4.8.3. Competitive scenario
    • 9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework/ reimbursement structure
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. India
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework/ reimbursement structure
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. Australia
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework/ reimbursement structure
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework/ reimbursement structure
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework/ reimbursement structure
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework/ reimbursement structure
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Mexico
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework/ reimbursement structure
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework/ reimbursement structure
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
  • 10.3.3. Key company market share analysis, 2023
  • 10.3.4. Mesa Laboratories, Inc. (Agena Bioscience, Inc.)
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Danaher Corporation (Beckman Coulter)
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Bio-Rad Laboratories, Inc
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. DIAGAST
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Grifols, S.A.
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. AXO Science
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Merck KGaA
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. Thermo Fisher Scientific
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Product benchmarking
    • 10.3.11.4. Strategic initiatives
  • 10.3.12. Immucor, Inc.
    • 10.3.12.1. Company overview
    • 10.3.12.2. Financial performance
    • 10.3.12.3. Product benchmarking
    • 10.3.12.4. Strategic initiatives
  • 10.3.13. BAG Diagnostics GmbH
    • 10.3.13.1. Company overview
    • 10.3.13.2. Financial performance
    • 10.3.13.3. Product benchmarking
    • 10.3.13.4. Strategic initiatives
  • 10.3.14. Seegene Inc.
    • 10.3.14.1. Company overview
    • 10.3.14.2. Financial performance
    • 10.3.14.3. Product benchmarking
    • 10.3.14.4. Strategic initiatives